References
- Colucci, M. A.; Moody, C. J.; Couch, G. D. Org. Biomol. Chem. 2008, 6, 637. https://doi.org/10.1039/b715270a
- Asche, C. Mini-Rev. Med. Chem. 2005, 5, 449. https://doi.org/10.2174/1389557053765556
- Alcain, F. J.; Villalba, J. M. Expert Opin. Ther. Patents 2007, 17, 649. https://doi.org/10.1517/13543776.17.6.649
- Martinez, R.; Chacon-Garcia, L. Curr. Med. Chem. 2005, 12, 127. https://doi.org/10.2174/0929867053363414
- Hande, K. R. Update on Cancer Therapeutics 2008, 3, 13. https://doi.org/10.1016/j.uct.2008.02.001
- Nitiss, J. L. Nat. Rev. 2009, 9, 338. https://doi.org/10.1038/nrc2607
- Topcu, Z. J. Clin. Pharm. Ther. 2001, 26, 405. https://doi.org/10.1046/j.1365-2710.2001.00368.x
- Garuti, L.; Roberti, M.; Pizzirani, D. Mini-Rev. Med. Chem. 2007, 7, 481. https://doi.org/10.2174/138955707780619626
- Lee, H.-J.; Kim, J. S.; Suh, M.-E.; Park, H. J.; Lee, S. K.; Rhee, H.-K.; Kim, H. J.; Seo, E.-K.; Kim, C.; Lee, C.-O.; Park Choo, H.- Y. Eur. J. Med. Chem. 2007, 42, 168. https://doi.org/10.1016/j.ejmech.2006.09.007
- Kim, J. S.; Rhee, H.-K.; Park, H. J.; Lee, I.-K.; Lee, S. K.; Suh, M.-E.; Lee, H. J.; Ryu, C.-K.; Park Choo, H.-Y. Bioorgan. Med. Chem. 2007, 15, 451. https://doi.org/10.1016/j.bmc.2006.09.040
- Kim, J. S.; Rhee, H.-K.; Park, H. J.; Lee, S. K.; Lee, C.-O.; Park Choo, H.-Y. Bioorgan. Med. Chem. 2008, 16, 4545. https://doi.org/10.1016/j.bmc.2008.02.049
- Rhee, H.-K.; Park, H. J.; Lee, S. K.; Lee, C.-O.; Park Choo H.-Y. Bioorgan. Med. Chem. 2007, 15, 1651. https://doi.org/10.1016/j.bmc.2006.12.012
- Cheng, C. C.; Dong, Q.; Liu, D.-F.; Luo, Y.; Liu, L. F.; Chen, A. Y.; Yu, C.; Savaraji, N.; Chou, T.-C. J. Med. Chem. 1993, 36, 4108. https://doi.org/10.1021/jm00077a016
- Lee, S. K.; Cui, B.; Mehta, R. R.; Kinghorn, A. D.; Pezzuto, J. M. Chem. -Biol. Interact. 1998, 115, 215. https://doi.org/10.1016/S0009-2797(98)00073-8
- Woo, S.; Jung, J.; Lee, C.; Kwon, Y.; Na, Y. Bioorg. Med. Chem. Lett. 2007, 17, 1163. https://doi.org/10.1016/j.bmcl.2006.12.030
- Chung, H.-J.; Rhee, H.-K.; Lee, S. K.; Park Choo, H.-Y. Chem. - Biol. Interact. 2011, in press.
Cited by
- ChemInform Abstract: Synthesis, Cytotoxicity and Topoisomerase II Inhibitory Activity of Benzonaphthofurandiones (V). vol.42, pp.46, 2011, https://doi.org/10.1002/chin.201146098
- ]furan-4,9-diones from 2-Hydroxy-1,4-Naphthoquinone and Nitroalkenes vol.2013, pp.36, 2013, https://doi.org/10.1002/ejoc.201300996
- The deep eutectic melt of sorbitol and metformin hydrochloride: synthesis of 3-substituted 2-aminonaphtho[2,3-b]furan-4,9-diones and their photophysical properties vol.6, pp.16, 2016, https://doi.org/10.1039/C5RA19619A
- Hydroarylation of 2-Aryloxybut-1-en-3-ynes via Pd/Acid-Catalyzed C−H Bond Activation: A Concise Synthesis of 2,3-Bismethylene-2,3-dihydrobenzofurans vol.12, pp.18, 2017, https://doi.org/10.1002/asia.201701079
- ]benzofurans vol.82, pp.21, 2017, https://doi.org/10.1021/acs.joc.7b02134
- Synthesis of Fused Dibenzofuran Derivatives via Palladium-Catalyzed Domino C–C Bond Formation and Iron-Catalyzed Cycloisomerization/Aromatization vol.81, pp.3, 2011, https://doi.org/10.1021/acs.joc.5b02637
- Crystal structure of 4-hydroxynaphtho[2,3-b]benzofuran-6,11-dione, C16H8O4 vol.235, pp.3, 2011, https://doi.org/10.1515/ncrs-2019-0809
- Crystal structure of 4-hydroxynaphtho[2,3-b]benzofuran-6,11-dione, C16H8O4 vol.235, pp.3, 2011, https://doi.org/10.1515/ncrs-2019-0809